Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism BCL11A inhibitors(B-cell lymphoma/leukemia 11A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Sickle Cell | Preclinical | United States | 15 Nov 2013 | |
| Beta-Thalassemia | Preclinical | United States | 15 Nov 2013 |





